CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More »

Adrian Ridge est nommé directeur général de Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Californie, 02 juill. 2024 (GLOBE NEWSWIRE) — À compter du 1er juillet 2024, Adrian Ridge est directeur général de Nikkiso Clean Energy & Industrial Gases Group, qui fait partie de la branche industrielle de Nikkiso Co. Ltd. Ridge succède à Peter Wagner, qui reste engagé au sein du conseil d’administration en tant que président […]

Read More »

Call for Nominations: 2024 Global Citizen Award

LONDON, July 02, 2024 (GLOBE NEWSWIRE) — Leading international residence and citizenship advisory firm Henley & Partners, in partnership with Andan Foundation, a Swiss non-profit humanitarian organization, is pleased to announce the call for nominations for the 2024 Global Citizen Award. Created ten years ago in 2014, the Global Citizen Award is a tribute that honors remarkable individuals […]

Read More »

In Rapid Rise of AI, Employers Turn to Business School Graduates for Human Skills

GMAC’s annual survey of corporate recruiters indicates high confidence, predicts strong hiring RESTON, Va., July 01, 2024 (GLOBE NEWSWIRE) —  Despite concerns about inflation and recession risk, employer confidence in graduate management education (GME) and its ability to prepare business school graduates to be successful in their organizations has reached new heights since the pandemic, […]

Read More »

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

Mr. Oliveira is an accomplished biopharmaceutical industry executive with nearly 25 years of commercial experience, building high-performing teams, and launching multiple successful pharmaceutical products WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, today announced the appointment […]

Read More »

Aleph Group Acquires Entravision’s Digital Advertising Business

Miami, July 01, 2024 (GLOBE NEWSWIRE) — Miami, FL – July 1st , 2024. Aleph Group, the global leader in connecting leading global digital media platforms with advertisers and consumers in primarily emerging markets, today announced the completion of its acquisition of Entravision Global Partners (“EGP”), the digital commercial partnership business unit of Entravision Communications Corporation. This  […]

Read More »

AACSB Sets Direction for Business Schools to Lead in AI

AACSB uses new report and global events to set strategic direction for business schools to advance education and lead boldly in AI. TAMPA, Fla., June 28, 2024 (GLOBE NEWSWIRE) — AACSB International (AACSB) is leading the way for business schools to utilize and innovate with AI. With a recently released report that explores how business […]

Read More »

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI) Innovation Studio, signaling a strategic investment in reshaping the execution of clinical trials today and into the future. The studio will develop and deploy AI and machine learning […]

Read More »